Physician

Ryan Bradford Rush, MD

According to 2025 Medicare claims, Ryan Rush, MD (NPI: 1720260151) practices ophthalmology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is PANHANDLE EYE GROUP, LLP (NPI: 1760571723; TIN: 752741195) and primary practice location at 79106-1835.

Rush's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,448 traditional Medicare patients, billed 255,392 HCPCS/CPT codes, and received $10,605,327 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 274 prescription claims across 98 beneficiaries totaling $25,832 in drug costs, led by Restasis Multidose (Cyclosporine). Open Payments data shows 1 records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,205,121 to $10,605,327. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.3M$11M2015 Medicare payment: $2,205,121 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,354,354 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,417,906 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,269,437 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $7,284,792 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $7,316,577 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,752,867 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,817,635 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,758,012 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $10,605,327 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,29924,676$2,205,121
20161,43728,255$2,354,354
20171,59527,513$2,417,906
20181,63232,583$5,269,437
20191,67134,931$7,284,792
20201,51126,839$7,316,577
20211,55829,298$7,752,867
20221,52857,272$7,817,635
20231,506223,353$9,758,012
20241,448255,392$10,605,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$47K2015 Drug cost: $9,990 (USD; Tot_Drug_Cst)2016 Drug cost: $22,602 (USD; Tot_Drug_Cst)2017 Drug cost: $34,583 (USD; Tot_Drug_Cst)2018 Drug cost: $42,339 (USD; Tot_Drug_Cst)2019 Drug cost: $42,327 (USD; Tot_Drug_Cst)2020 Drug cost: $47,169 (USD; Tot_Drug_Cst)2021 Drug cost: $29,515 (USD; Tot_Drug_Cst)2022 Drug cost: $23,168 (USD; Tot_Drug_Cst)2023 Drug cost: $28,629 (USD; Tot_Drug_Cst)2024 Drug cost: $25,832 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015130211$9,990
2016164327$22,602
2017179383$34,583
2018185457$42,339
2019187422$42,327
2020157469$47,169
2021121358$29,515
202289255$23,168
202387237$28,629
202498274$25,832

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye1,2852,873$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,3944,844$88
92134Imaging of retina1,4084,963$28
92201Extended exam of the back part of the eye with retinal drawing8381,988$19
92202Extended exam of the back part of the eye with optic nerve drawing1,0182,918$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Restasis MultidoseCyclosporine12364$6,170
CombiganBrimonidine Tartrate/Timolol16643$4,637
Prednisolone AcetatePrednisolone Acetate962,162$3,484
MoxifloxacinMoxifloxacin Hcl46523$1,145
TravoprostTravoprost11496$1,111

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$20,065US Retina LLC

FAQ

What Medicare data is available for Ryan Bradford Rush, MD?

Tedicare shows public-source Medicare data for Ryan Bradford Rush, MD (NPI 1720260151), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Bradford Rush, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Bradford Rush, MD?

Ryan Bradford Rush, MD is linked to PANHANDLE EYE GROUP, LLP (billing NPI 1760571723) in the available physician profile data.

Does Ryan Bradford Rush, MD have Open Payments data?

Ryan Bradford Rush, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.